402 related articles for article (PubMed ID: 19388207)
1. Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors.
Salminen A; Ojala J; Kauppinen A; Kaarniranta K; Suuronen T
Prog Neurobiol; 2009 Feb; 87(3):181-94. PubMed ID: 19388207
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer's pathology.
Salminen A; Ojala J; Suuronen T; Kaarniranta K; Kauppinen A
J Cell Mol Med; 2008 Dec; 12(6A):2255-62. PubMed ID: 18793350
[TBL] [Abstract][Full Text] [Related]
3. Age-related macular degeneration: activation of innate immunity system via pattern recognition receptors.
Kaarniranta K; Salminen A
J Mol Med (Berl); 2009 Feb; 87(2):117-23. PubMed ID: 19009282
[TBL] [Abstract][Full Text] [Related]
4. The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease.
Webers A; Heneka MT; Gleeson PA
Immunol Cell Biol; 2020 Jan; 98(1):28-41. PubMed ID: 31654430
[TBL] [Abstract][Full Text] [Related]
5. Cross Talk Between Brain Innate Immunity and Serotonin Signaling Underlies Depressive-Like Behavior Induced by Alzheimer's Amyloid-β Oligomers in Mice.
Ledo JH; Azevedo EP; Beckman D; Ribeiro FC; Santos LE; Razolli DS; Kincheski GC; Melo HM; Bellio M; Teixeira AL; Velloso LA; Foguel D; De Felice FG; Ferreira ST
J Neurosci; 2016 Nov; 36(48):12106-12116. PubMed ID: 27903721
[TBL] [Abstract][Full Text] [Related]
6. Danger-Sensing/Patten Recognition Receptors and Neuroinflammation in Alzheimer's Disease.
Chiarini A; Armato U; Hu P; Dal Prà I
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33261147
[TBL] [Abstract][Full Text] [Related]
7. Phagocytosis of amyloid-beta and inflammation: two faces of innate immunity in Alzheimer's disease.
Fiala M; Cribbs DH; Rosenthal M; Bernard G
J Alzheimers Dis; 2007 Jul; 11(4):457-63. PubMed ID: 17656824
[TBL] [Abstract][Full Text] [Related]
8. Danger-associated molecular patterns in Alzheimer's disease.
Venegas C; Heneka MT
J Leukoc Biol; 2017 Jan; 101(1):87-98. PubMed ID: 28049142
[TBL] [Abstract][Full Text] [Related]
9. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
Ferrera D; Mazzaro N; Canale C; Gasparini L
Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
[TBL] [Abstract][Full Text] [Related]
10. The early involvement of the innate immunity in the pathogenesis of late-onset Alzheimer's disease: neuropathological, epidemiological and genetic evidence.
Eikelenboom P; Veerhuis R; van Exel E; Hoozemans JJ; Rozemuller AJ; van Gool WA
Curr Alzheimer Res; 2011 Mar; 8(2):142-50. PubMed ID: 21345167
[TBL] [Abstract][Full Text] [Related]
11. MyD88 acts as an adaptor protein for inflammatory signalling induced by amyloid-β in macrophages.
O'Halloran S; O'Leary A; Kuijper T; Downer EJ
Immunol Lett; 2014 Nov; 162(1 Pt A):109-18. PubMed ID: 25124962
[TBL] [Abstract][Full Text] [Related]
12. Future horizons in Alzheimer's disease research.
Wisniewski T; Drummond E
Prog Mol Biol Transl Sci; 2019; 168():223-241. PubMed ID: 31699317
[TBL] [Abstract][Full Text] [Related]
13. Targeting Neuroinflammation to Treat Alzheimer's Disease.
Ardura-Fabregat A; Boddeke EWGM; Boza-Serrano A; Brioschi S; Castro-Gomez S; Ceyzériat K; Dansokho C; Dierkes T; Gelders G; Heneka MT; Hoeijmakers L; Hoffmann A; Iaccarino L; Jahnert S; Kuhbandner K; Landreth G; Lonnemann N; Löschmann PA; McManus RM; Paulus A; Reemst K; Sanchez-Caro JM; Tiberi A; Van der Perren A; Vautheny A; Venegas C; Webers A; Weydt P; Wijasa TS; Xiang X; Yang Y
CNS Drugs; 2017 Dec; 31(12):1057-1082. PubMed ID: 29260466
[TBL] [Abstract][Full Text] [Related]
14. A possible new role for Aβ in vascular and inflammatory dysfunction in Alzheimer's disease.
Zamolodchikov D; Strickland S
Thromb Res; 2016 May; 141 Suppl 2():S59-61. PubMed ID: 27207427
[TBL] [Abstract][Full Text] [Related]
15. Role of Toll Like Receptor 4 in Alzheimer's Disease.
Calvo-Rodriguez M; García-Rodríguez C; Villalobos C; Núñez L
Front Immunol; 2020; 11():1588. PubMed ID: 32983082
[TBL] [Abstract][Full Text] [Related]
16. Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease.
Blasko I; Grubeck-Loebenstein B
Drugs Aging; 2003; 20(2):101-13. PubMed ID: 12534311
[TBL] [Abstract][Full Text] [Related]
17. Neuroinflammatory responses in Alzheimer's disease.
Dansokho C; Heneka MT
J Neural Transm (Vienna); 2018 May; 125(5):771-779. PubMed ID: 29273951
[TBL] [Abstract][Full Text] [Related]
18. Deletion of the type-1 interferon receptor in APPSWE/PS1ΔE9 mice preserves cognitive function and alters glial phenotype.
Minter MR; Moore Z; Zhang M; Brody KM; Jones NC; Shultz SR; Taylor JM; Crack PJ
Acta Neuropathol Commun; 2016 Jul; 4(1):72. PubMed ID: 27400725
[TBL] [Abstract][Full Text] [Related]
19. Innate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatment.
Serpente M; Bonsi R; Scarpini E; Galimberti D
Neuroimmunomodulation; 2014; 21(2-3):79-87. PubMed ID: 24557039
[TBL] [Abstract][Full Text] [Related]
20. The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease.
Minter MR; Taylor JM; Crack PJ
J Neurochem; 2016 Feb; 136(3):457-74. PubMed ID: 26509334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
